EUVIMEDEUVIMED entdecken
Crossref

Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signaling

Xuemei Wang, Shuang Zhou, Xiaomin Hu, Chuan Ye, Qixing Nie, Kai Wang, Sen Yan, Jun Lin, Feng Xu, Meng Li, Qing Wu, Lulu Sun und 11 weitere

Cell Host & Microbe · 2024-06 · 32 (6) · 964-979.e7

DOI: 10.1016/j.chom.2024.04.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2024-06. Verfasst von Xuemei Wang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, NHC Key Laboratory of Medical Immunology, Medicine Innovation Center for Fundamental Rese…. Hauptthemen laut MEDLINE: Candida albicans, Atherosclerosis, Basic Helix-Loop-Helix Proteins, Signal Transduction. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Peking University, Ministry of Science and Technology of the People's Republic of China, Shandong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota is closely linked to atherosclerosis. However, the role of intestinal fungi, essential members of the complex microbial community, in atherosclerosis is poorly understood. Herein, we show that gut fungi dysbiosis is implicated in patients with dyslipidemia, characterized by higher levels of Candida albicans (C. albicans), which are positively correlated with plasma total cholesterol and low-density lipoprotein-cholesterol (LDL-C) levels. Furthermore, C. albicans colonization aggravates atherosclerosis progression in a mouse model of the disease. Through gain- and loss-of-function studies, we show that an intestinal hypoxia-inducible factor 2α (HIF-2α)-ceramide pathway mediates the effect of C. albicans. Mechanistically, formyl-methionine, a metabolite of C. albicans, activates intestinal HIF-2α signaling, which drives increased ceramide synthesis to accelerate atherosclerosis. Administration of the HIF-2α selective antagonist PT2385 alleviates atherosclerosis in mice by reducing ceramide levels. Our findings identify a role for intestinal fungi in atherosclerosis progression and highlight the intestinal HIF-2α-ceramide pathway as a target for atherosclerosis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candida albicansAtherosclerosisBasic Helix-Loop-Helix ProteinsSignal TransductionCeramidesAnimalsMiceHumansDisease Models, AnimalMice, Inbred C57BLMaleGastrointestinal MicrobiomeIntestinesDysbiosisFemaleCandidiasisEndothelial PAS Domain-Containing Protein 1

Stichwörter der Autor:innen

Candida albicansatherosclerosisintestinal HIF-2αintestinal fungal metabolitesintestinal fungi

Substanzen

Basic Helix-Loop-Helix ProteinsCeramidesEndothelial PAS Domain-Containing Protein 1

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medical Sciences, NHC Key Laboratory of Medical Immunology, Medicine Innovation Center for Fundamental Research on Major Immunology-related Diseases, Peking University, Beijing…
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China; National Clinical Research Center f…
  • Clinical Pharmacology and Pharmacometrics, Janssen China Research & Development, Beijing, China.
  • Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing 100191, China; State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gyn…

Förderung

  • Peking University
  • Ministry of Science and Technology of the People's Republic of China
  • Shandong University
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Wang, X., Zhou, S., Hu, X., Ye, C., Nie, Q., Wang, K., Yan, S., Lin, J., Xu, F., Li, M., Wu, Q., Sun, L., Liu, B., Zhang, Y., Yun, C., Wang, X., Liu, H., Yin, W. B., Zhao, D., …, & Pang, Y. (2024). Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signaling. Cell Host & Microbe, 32(6), 964-979.e7. https://doi.org/10.1016/j.chom.2024.04.017

Vancouver

Wang X, Zhou S, Hu X, Ye C, Nie Q, Wang K, et al. Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signaling. Cell Host & Microbe. 2024;32(6):964-979.e7. doi:10.1016/j.chom.2024.04.017

BibTeX
@article{Wang2024,
  author = {Wang, Xuemei and Zhou, Shuang and Hu, Xiaomin and Ye, Chuan and Nie, Qixing and Wang, Kai and Yan, Sen and Lin, Jun and Xu, Feng and Li, Meng and Wu, Qing and Sun, Lulu and Liu, Bo and Zhang, Yi and Yun, Chuyu and Wang, Xian and Liu, Huiying and Yin, Wen-Bing and Zhao, Dongyu and Hang, Jing and Zhang, Shuyang and Jiang, Changtao and Pang, Yanli},
  title = {Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signaling},
  journal = {Cell Host & Microbe},
  year = {2024},
  volume = {32},
  number = {6},
  pages = {964--979.e7},
  doi = {10.1016/j.chom.2024.04.017}
}
Kostenlos starten →